Dapagliflozin 10 MG Oral Tablet
Sponsors
University of Oxford, Shanghai Zhongshan Hospital, NHS Greater Glasgow and Clyde, University Health Network, Toronto, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
Conditions
Acute Myocardial Infarction With ST ElevationCisplatin NephrotoxicityDiabetes Mellitus, Type 1Epicardial FatHeart FailureKidney Transplant RecipientsPost-transplant Diabetes MellitusSTEMI - ST Elevation Myocardial Infarction
Phase 2
Dapagliflozin During Exercise for the PrevenTion of Hypoglycaemia
TerminatedNCT03537131
Start: 2018-06-02End: 2021-07-14Updated: 2022-05-18
Protecting the Kidney's Proximal Tubules From Platinum-Based Chemotherapy Toxicity
RecruitingNCT07018622
Start: 2025-05-07End: 2026-10-30Target: 46Updated: 2026-03-11
Phase 3
DAPAgliflozin Versus Thiazide Diuretic in Patients With Heart Failure and Diuretic RESISTance
NCT04860011
Start: 2021-04-27End: 2023-04-03Updated: 2023-04-10
Efficacy, Mechanisms and Safety of SGLT2 Inhibitors in Kidney Transplant Recipients
CompletedNCT04965935
Start: 2021-07-15End: 2024-08-30Updated: 2025-03-20
Effect of Glp-1 and Antidiabetic sgLT2 Agents for myoCardial infarcTion and Ultrasensitive Inflammatory Surveillance (GALACTUS Trial)
RecruitingNCT07295223
Start: 2025-12-30End: 2026-09-30Target: 44Updated: 2026-01-05
Epicardial Cardiac Fat-CT (EPIC-CT)
RecruitingNCT07297589
Start: 2025-12-30End: 2027-03-31Target: 136Updated: 2026-01-02